Antiviral Resistance Analysis Requested In FDA Draft Guidance
An analysis of resistance activity associated with antiviral drugs should be conducted prior to the initiation of clinical studies, FDA recommends in a draft guidance released May 25
An analysis of resistance activity associated with antiviral drugs should be conducted prior to the initiation of clinical studies, FDA recommends in a draft guidance released May 25